The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Induction of Tumors in Mice by Genomic Hypomethylation
Abstract
Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 ( Dnmt1 ) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003)”
From The Aging Epigenome (2016) · cites this paper as Gaudet et al., 2003
In the citing paper
“Indeed, the global DNA hypomethylation, especially occurring on intragenic regions, is a general feature of most tumours [35][36][37] .”
From Intragenic DNA methylation prevents spurious transcription initiation (2017) · cites this paper as [36]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Self-citation
Research works printed but not linked: 3
- S. Cory, D. L. Vaux, A. Strasser, A. W. Harris, J. M. Adams, Cancer Res.59 (suppl.), 1685s (1999).
- E. Wainfan, L. A. Poirier, Cancer Res.52, 2071s (1992).
- V. Zagonelet al., Leukemia7 (suppl. 1), 30 (1993).
Cited by
Items 301–400 of 1,001
Prediction of methylated CpGs in DNA sequences using a support vector machine
Bhasin, M., Zhang, H., Reinherz, E. L., & Reche, P. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.002 · Cited by 117
“Thus, in cancer cells, the usual pattern of DNA methylation is reversed, with hypermethylation of CpG islands in promoter genes and overall exonic hypomethylation [21–23].”
BackgroundDnmt1 Expression in Pre- and Postimplantation Embryogenesis and the Maintenance of IAP Silencing
Gaudet, F., Rideout, W. M., Meissner, A., Dausman, J. A., Leonhardt, H., & Jaenisch, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1640-1648.2004 · Cited by 121
“To test this hypothesis, we crossed males containing a hypomorphic allele of Dnmt1 (Dnmt1) and the A allele with C57BL/6 females heterozygous for the Dnmt1 null allele to generate compound heterozygous Dnmt1 mice, which express 10% of wild-type levels of Dnmt1 and are globally hypomethylated (7).”
BackgroundMethodSelf-citationNutrigenetics in Cancer Research—Folate Metabolism and Colorectal Cancer
Ulrich, C. M. (2005) · Journal of Nutrition · doi:10.1093/jn/135.11.2698 · Cited by 116
DNA Methylation, Smooth Muscle Cells, and Atherogenesis
Hiltunen, M., & Ylä‐Herttuala, S. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000092871.30563.41 · Cited by 116
Ly, A., Hoyt, L., Crowell, J., & Kim, Y. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4554 · Cited by 133
DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID
Domínguez, P. M., Teater, M. R., Chambwe, N., Kormáksson, M., Redmond, D., Ishii, J. K., Vuong, B. Q., Chaudhuri, J., Melnick, A. M., Vasanthakumar, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.036 · Cited by 124
“Such broad extension of hypomethylation could, in turn, have various consequences, including instability of transposable elements, chromosomal translocations, and gene deregulation, as suggested by the Jaenisch’s group (Gaudet et al., 2003).”
Epigenetic mechanisms in developmental programming of adult disease
Chen, M., & Zhang, L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.008 · Cited by 126
“Reduction of DNMT1 expression can result in genome-wide hypomethylation in all tissues and leads to tumor development in later life [29].”
BackgroundIwagami, S., Baba, Y., Watanabe, M., Shigaki, H., Miyake, K., Ishimoto, T., Iwatsuki, M., Sakamaki, K., Ohashi, Y., & Baba, H. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826d8602 · Cited by 120
Chik, F., & Szyf, M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq221 · Cited by 118
DNA demethylation and cancer: therapeutic implications
Szyf, M., Pakneshan, P., & Rabbani, S. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.04.009 · Cited by 118
MSRE-PCR for analysis of gene-specific DNA methylation
Melnikov, A. A., Gartenhaus, R. B., Levenson, A. S., Motchoulskaia, N. A., & Chernokhvostov, V. V. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni092 · Cited by 129
“Global hypomethylation (6) is linked to genomic instability of a tumor (7), whereas hypermethylation of specific genes correlates with their silencing (8) and can induce point mutations owing to spontaneous deamination of 5me-C (transversion C>T) (9).”
BackgroundBlood leukocyte DNA hypomethylation and gastric cancer risk in a high‐risk Polish population
Hou, L., Wang, H., Sartori, S., Gawron, A. J., Lissowska, J., Bollati, V., Tarantini, L., Zhang, F. F., Zatoński, W. A., Chow, W., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25190 · Cited by 118
“Mice with global hypomethylation showed a tendency to develop multiple malignancies.(2) Many types of cancer cells and premalignant adenomas have been found to exhibit a reduced level of CpG sequence methylation globally.”
BackgroundEpigenomes as therapeutic targets
Hamm, C. A., & Costa, F. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.003 · Cited by 122
Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer
Romanish, M. T., Cohen, C., & Mager, D. L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.005 · Cited by 129
“[105] Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al.”
BackgroundDNA methylation dynamics in cellular commitment and differentiation
Suelves, M., Carrió, E., Núñez‐Álvarez, Y., & Peinado, M. A. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw017 · Cited by 139
Aberrant DNA Methylation and Prostate Cancer
Majumdar, S., Buckles, E. L., Estrada, J. J., & Koochekpour, S. (2011) · Current Genomics · doi:10.2174/138920211797904061 · Cited by 127
“Cells that are defective in the components of DNA repair pathways exhibit higher rates of spontaneous DNA mutations, which can lead to cancer [38].”
BackgroundWorthley, D. L., Whitehall, V., Buttenshaw, R. L., Irahara, N., Greco, S. A., Ramsnes, I., Mallitt, K., Leu, R. K. L., Winter, J. M., Hu, Y. C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.449 · Cited by 113
“There is already an established relationship between global DNA hypomethylation and CIN in cancer (Eden et al., 2003; Gaudet et al., 2003; Chen et al., 2007; Esteller, 2008; Ogino et al., 2008).”
BackgroundDNA hypermethylation as a chemotherapy target
Ren, J., Singh, B. N., Huang, Q., Li, Z., Gao, Y., Mishra, P., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.02.003 · Cited by 114
Is There a Link Between Genome-Wide Hypomethylation in Blood and Cancer Risk?
Brennan, K., & Flanagan, J. M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0316 · Cited by 117
“6 cancers in animal models with experimentally induced hypomethylation suggest a causative role [30, 41-43].”
BackgroundMechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer
Sansom, O. J., Maddison, K., & Clarke, A. R. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0812 · Cited by 128
“and DNMT1 hypomorphic mice expressing 10% of normal levels of this gene show runting at birth, and at 4–8 months of age develop aggressive T-cell lymphomas that display a high frequency of chromosome 15 trisomy”
BackgroundInhibitors of DNA methylation in the treatment of hematological malignancies and MDS
Leone, G. G. M., Voso, M. T., Teofili, L., & Lübbert, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00207-9 · Cited by 123
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Ibrahim, J., Peeters, M., Camp, G. V., & de Beeck, K. O. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.10.015 · Cited by 128
DNA and histone methylation in gastric carcinogenesis
Calcagno, D. Q., Gigek, C. O., Chen, E. S., Burbano, R. R., & Smith, M. D. A. C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1182 · Cited by 112
BRCA1 affects global DNA methylation through regulation of DNMT1
Shukla, V., Coumoul, X., Lahusen, T. J., Wang, R.-H., Xu, X., Vassilopoulos, A., Xiao, C., Lee, M., Man, Y.-G., Ouchi, M., et al. (2010) · Cell Research · doi:10.1038/cr.2010.128 · Cited by 114
Jiang, R., Jones, M. J., Sava, F., Kobor, M. S., & Carlsten, C. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0071-3 · Cited by 120
“In some cases, demethylation of Alu and LINE1 increases genomic instability, which could mean that DE exposure predisposes some cells to genomic rearrangements [53-55].”
BackgroundBurgio, E., Piscitelli, P., & Migliore, L. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091971 · Cited by 160
“The first studies showing the effects of IR on the epigenome date back to about twenty years ago: they documented a hypomethylation of the main sequence of DNA [57,58], with destabilizing and potentially procancerogenic effects on the genome [59,60].”
BackgroundMund, C., Hackanson, B. W., Stresemann, C., Lübbert, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0695 · Cited by 119
Marsit, C. J., Christensen, B. C., Houseman, E. A., Karagas, M. R., Wrensch, M., Yeh, R.-F., Nelson, H. H., Wiemels, J. L., Zheng, S., Posner, M. R., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp006 · Cited by 115
How mammalian transcriptional repressors work
Thiel, G., Lietz, M., & Hohl, M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04174.x · Cited by 122
Promoter hypomethylation regulates CD133 expression in human gliomas
Tabu, K., Sasai, K., Kimura, T., Wang, L., Aoyanagi, E., Kohsaka, S., Tanino, M. A., Nishihara, H., & Tanaka, S. (2008) · Cell Research · doi:10.1038/cr.2008.270 · Cited by 121
Smith, I. M., Glazer, C. A., Mithani, S. K., Ochs, M. F., Sun, W., Bhan, S., Vostrov, A. A., Abdullaev, Z., Lobanenkov, V. V., Gray, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004961 · Cited by 113
“and develop aggressive T-cell lymphomas with chromosomal instability [4].”
BackgroundFini, L., Selgrad, M., Fogliano, V., Graziani, G., Romano, M., Hotchkiss, E. C., Daoud, Y., Vol, E. B. D., Boland, C. R., & Ricciardiello, L. (2007) · Journal of Nutrition · doi:10.1093/jn/137.12.2622 · Cited by 106
Zampieri, M., Passananti, C., Calabrese, R., Perilli, M., Corbi, N., Cave, F. D., Guastafierro, T., Bacalini, M. G., Reale, A., Amicosante, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004717 · Cited by 126
“[15], cancer [4,6,7,16], disruption of nucleolar architecture [17],”
BackgroundDNA Methylation and Apoptosis Resistance in Cancer Cells
Hervouet, É., Cheray, M., Vallette, F. M., & Cartron, P. (2013) · Cells · doi:10.3390/cells2030545 · Cited by 106
“Invalidation of Dnmt1 has been associated to global DNA methylation, chromosal instability and lymphomas [160].”
BackgroundThe emerging role of epigenetics in cellular and organismal aging
Bandyopadhyay, D., & Medrano, E. E. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.009 · Cited by 104
Suppression of Intestinal Neoplasia by Deletion of Dnmt3b
Lin, H., Yamada, Y., Nguyen, S. P., Linhart, H., Jackson‐Grusby, L., Meissner, A., Meletis, K., Lo, G., & Jaenisch, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2976-2983.2006 · Cited by 104
“For example, reduced Dnmt1 activity was demonstrated to inhibit adenoma formation in Apc mice but to promote formation of lymphomas in the thymus and of sarcomas in soft tissues (9, 12).”
BackgroundInfluentialSelf-citationSmall Molecule Oxidation Products Trigger Disease-Associated Protein Misfolding
Bieschke, J., Zhang, Q., Bosco, D. A., Lerner, R. A., Powers, E. T., Wentworth, P., & Kelly, J. W. (2006) · Accounts of Chemical Research · doi:10.1021/ar0500766 · Cited by 113
Non-targeted radiation effects—An epigenetic connection
Ilnytskyy, Y., & Kovalchuk, O. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.06.014 · Cited by 115
Helm, J. S., & Rudel, R. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02752-z · Cited by 76
Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1 and Tet1
Frauer, C., Rottach, A., Meilinger, D., Bultmann, S., Fellinger, K., Hasenöder, S., Wang, M., Qin, W., Söding, J., Spada, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016627 · Cited by 134
“Thus, Dnmt1 maintains methylation patterns with high fidelity and is essential for embryonic development and genome integrity [9,14,15].”
BackgroundSelf-citationRaiche, J., Rodriguez‐Juarez, R., Pogribny, I. P., & Kovalchuk, O. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.002 · Cited by 103
Milutinovic, S., Brown, S. E., Zhuang, Q., & Szyf, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312823200 · Cited by 103
Patra, S. K., Patra, A., Rizzi, F., Ghosh, T. C., & Bettuzzi, S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9118-y · Cited by 109
“The cloning, mutational as well as conditional knock out and covalent trapping of DNMT1 showed that there are various regulatory mechanisms acting on this enzyme that is fundamental for embryonic development [48] and induction of cell transformation [96].”
BackgroundYoo, C. B., Chuang, J. C., Byun, H., Egger, G., Yang, A. S., Dubeau, L., Long, T. I., Laird, P. W., Márquez, V. E., & Jones, P. A. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-07-0008 · Cited by 109
“This is a significant finding that strengthens the notion that zebularine is relatively nontoxic in mice, and which may allay the concerns that the use of demethylating agents is detrimental to the operation of normal biological processes (16, 17).”
BackgroundYoshida, M., Nosaka, K., Yasunaga, J., Nishikata, I., Morishita, K., & Matsuoka, M. (2003) · Blood · doi:10.1182/blood-2003-07-2482 · Cited by 100
Linhart, H., Troen, A. M., Bell, G. W., Cantu, E., Chao, W., Morán, E., Steine, E. J., He, T., & Jaenisch, R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.016 · Cited by 102
Self-citationEpigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins
Montoya-Durango, D. E., Liu, Y., Teneng, I., Kalbfleisch, T., Lacy, M. E., Steffen, M. C., & Ramos, K. S. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.02.011 · Cited by 105
“Global hypomethylation of 5-methylcytosine and CpG islands leads to L1 activation, chromosomal instability and elevated mutation rates [24,25], hence linking retrotransposition and tumorigenenesis [26,27].”
BackgroundCruickshanks, H. A., & Tufarelli, C. (2009) · Genomics · doi:10.1016/j.ygeno.2009.08.013 · Cited by 114
“Indeed, loss of methylation and activation of transposable elements have been proposed as factors promoting malignancy progression [21,22,24].”
Global DNA hypomethylation in cancer: review of validated methods and clinical significance
Toraño, E. G., Petrus-Reurer, S., Fernández, A. F., & Fraga, M. F. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0902 · Cited by 112
Shigaki, H., Baba, Y., Watanabe, M., Murata, A., Iwagami, S., Miyake, K., Ishimoto, T., Iwatsuki, M., & Baba, H. (2012) · Gastric Cancer · doi:10.1007/s10120-012-0209-7 · Cited by 110
“First, genome-wide DNA hypomethylation has been shown to be associated with genomic instability [10–12, 37],”
BackgroundEarly onset sporadic colorectal cancer: Worrisome trends and oncogenic features
Cavestro, G. M., Mannucci, A., Zuppardo, R. A., Leo, M. D., Stoffel, E. M., & Tonon, G. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.02.009 · Cited by 108
Jian, Y. U., Zhang, H. Y., Zhong, Z., Lu, W., Wang, Y., & Jingde, Z. H. U. (2003) · Cell Research · doi:10.1038/sj.cr.7290177 · Cited by 115
Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy
Gowher, H., & Jeltsch, A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1308 · Cited by 100
Teng, I.-W., Hou, P., Lee, K., Chu, P., Yeh, K., Jin, V. X., Tseng, M., Tsai, S., Chang, Y., Wu, C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3418 · Cited by 106
“Hypomethylation and/or hypermethylation of specific loci, including tumor suppressor loci, were strongly associated with transformation and carcinogenesis (7, 8), and genetic knockout of the DNA methyltransferases (DNMTs), resulted in global hypomethylation and tumorigenesis (9, 10).”
BackgroundGenomic Methylation of Leukocyte DNA in Relation to Colorectal Adenoma Among Asymptomatic Women
Lim, U., Flood, A. P., Choi, S., Albanes, D., Cross, A. J., Schatzkin, A. G., Sinha, R. R., Katki, H. A., Cash, B. D., Schoenfeld, P. S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.013 · Cited by 99
Jia, Y., Li, P., Fang, L., Zhu, H., Xu, L., Cheng, H., Zhang, J., Li, F., Feng, Y., Li, Y., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.7 · Cited by 101
Single-Cell Sequencing Technologies: Current and Future
Liang, J., Cai, W., & Sun, Z. S. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.09.005 · Cited by 112
Rai, K., Sarkar, S., Broadbent, T. J., Voas, M. G., Grossmann, K. F., Nadauld, L. D., Dehghanizadeh, S., Hagos, F. T., Li, Y., Toth, R. K., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.030 · Cited by 98
“Consistent with this possibility, Dnmt1 hypomorph mice show genomic instability and develop T cell lymphomas (Gaudet et al., 2003).”
BackgroundThe role of epigenetic alterations in pancreatic cancer
Sato, N., & Goggins, M. (2006) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-005-1057-1 · Cited by 102
Global analysis of DNA methylation in early-stage liver fibrosis
Komatsu, Y., Waku, T., Iwasaki, N., Ono, W., Yamaguchi, C., & Yanagisawa, J. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-5 · Cited by 103
“cancer in mammals, involving human, suggesting that carcinogenesis results from DNA hypermethylation as well as DNA hypomethylation [38-40].”
BackgroundNatsume, A., Wakabayashi, T., Tsujimura, K., Shimato, S., Ito, M., Kuzushima, K., Kondo, Y., Sekido, Y., Kawatsura, H., Narita, Y., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23407 · Cited by 93
Epigenetics and the plasticity of differentiation in normal and cancer stem cells
Lotem, J., & Sachs, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209816 · Cited by 104
“…in which reducing the level of DNA methylation to 10% of normal levels by introducing a hypomorphic allele of the DNA methyltransferase gene Dnmt1 was sufficient to induce cancer development in mice (Gaudet et al., 2003), presumably due to induction of chromosome instability (Eden et al., 2003).”
BackgroundThe optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer
Komarova, N. L., & Wodarz, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401943101 · Cited by 93
Heideman, M. R., Wilting, R. H., Yanover, E., Velds, A., de Jong, J., Kerkhoven, R. M., Jacobs, H., Wessels, L. F. A., & Dannenberg, J. (2013) · Blood · doi:10.1182/blood-2012-08-450916 · Cited by 104
DynamicAluMethylation during Normal Development, Aging, and Tumorigenesis
Luo, Y., Lu, X., & Xie, H. (2014) · BioMed Research International · doi:10.1155/2014/784706 · Cited by 112
“Carrying a hypomorphic Dnmt1 allele, the mice with the hypomethylated genome would develop aggressive T cell lymphomas with a high frequency of chromosomal aberration [76].”
BackgroundDNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression
Wang, Y., Kamarova, Y., Shen, K. C., Jiang, Z., Hahn, M., Wang, Y., & Brooks, S. C. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.10.2073 · Cited by 98
Recreational and household physical activity at different time points and DNA global methylation
White, A. J., Sandler, D. P., Bolick, S. C. E., Xu, Z., Taylor, J. A., & DeRoo, L. A. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.013 · Cited by 96
The genome-wide mutational consequences of DNA hypomethylation
Besselink, N. J. M., Keijer, J. P., Vermeulen, C., Boymans, S., de Ridder, J., van Hoeck, A., Cuppen, E. P. J. G., & Kuijk, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-33932-3 · Cited by 109
Folate and One-Carbon Metabolism and Its Impact on Aberrant DNA Methylation in Cancer
Liu, J., & Ward, R. L. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00004-3 · Cited by 104
Costea, T., Vlad, O., Miclea, L. C., Ganea, C., Szöllõsi, J., & Mocanu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020401 · Cited by 101
Epigenetic programming of mesenchymal stem cells from human adipose tissue
Boquest, A. C., Noer, A., & Collas, P. (2006) · Stem Cell Reviews and Reports · doi:10.1007/bf02698059 · Cited by 102
Chen, S., Raval, A., Johnson, A. J., Hertlein, E. K., Liu, T.-H., Jin, V. X., Sherman, M. H., Liu, S., Dawson, D. W., Williams, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906455106 · Cited by 97
“There is evidence that epigenetic alterations could precede the initiation of tumorigenesis as exemplified by the recent discoveries of epimutations in MLH1 or MSH2 predisposing to colorectal cancer (8), or the loss of DNMT1 activity in mouse models developing T-cell lymphoma (9).”
BackgroundThe Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
Kerr, K. M., Galler, J. S., Hagen, J. A., Laird, P. W., & Laird‐Offringa, I. A. (2007) · Disease Markers · doi:10.1155/2007/985474 · Cited by 94
“Mouse experiments with DNA methyltransferase hypomorphs have demonstrated that reducing global methylation severely limits the development colon adenocarcinoma, while promoting lymphomas, cancers that appear to rely heavily on chromosomal rearrangements [87,88].”
BackgroundDNA methylation dynamics at transposable elements in mammals
Jansz, N. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190039 · Cited by 117
Demethylation of MAGE promoters during gastric cancer progression
Honda, T., Tamura, G., Waki, T., Kawata, S., Terashima, M., Nishizuka, S., & Motoyama, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601600 · Cited by 89
“…tumour-related genes (Choi et al, 2001; Jones and Takai, 2001; Kim et al, 2001; Goodman and Watson, 2002; Jones and Baylin, 2002) as well as global DNA hypomethylation (Eden et al, 2003; Gaudet et al, 2003; Lengauer, 2003), have been recognised as important contributors to carcinogenesis in humans.”
BackgroundBjaanæs, M. M., Fleischer, T., Halvorsen, A. R., Daunay, A., Busato, F., Solberg, S. K., Jørgensen, L. H., Kure, E. H., Edvardsen, H., Børresen‐Dale, A., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.021 · Cited by 89
“The reason for this is unknown, but hypomethylation is often associated with genomic instability that can lead to mutations (Gaudet et al., 2003) or the other way around; that TP 53 mutation affects affect important genes such as DNA 50-cytosine-methyltransferases (DNMT) (Lin et al., 2010) that…”
BackgroundDnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells
Kim, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh912 · Cited by 89
Genome-wide hypomethylation in cancer may be a passive consequence of transformation
Wild, L., & Flanagan, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.03.003 · Cited by 113
Epigenetic changes in virus-associated human cancers
Hsin Pai, L. I., Leu, Y. W., & Chang, Y. (2005) · Cell Research · doi:10.1038/sj.cr.7290295 · Cited by 89
Li, J., Harris, R. A., Cheung, S. W., Coarfa, C., Jeong, M., Goodell, M. A., White, L. D., Patel, A., Kang, S.-H. L., Shaw, C. A., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002692 · Cited by 93
“Mutations in the mouse homolog of methyltransferase DNMT1 have been shown to cause genomic instability [32].”
BackgroundKwon, M. J., Kim, S.-S., Choi, Y., Jung, H. S., Balch, C., Kim, S.-H., Song, Y. S., Márquez, V. E., Nephew, K. P., & Shin, Y. K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp336 · Cited by 93
Trials, Tribulations, and Trends in Tumor Modeling in Mice
Schuh, J. C. L. (2004) · Toxicologic Pathology · doi:10.1080/01926230490424770 · Cited by 89
“…metastasis (Fausto, 1999), cell adhesion dysfunction (Herzig and Christofori, 2002), telomere dysfunction (Goytisolo and Blasco, 2002; Artandi, 2002; Granger et al., 2002), ribosomal RNA modification (Ruggero et al., 2003), and DNA hypomethylation (Goodman and Watson, 2002; Gaudet et al., 2003).”
BackgroundTang, Q., Pan, F., Yang, J., Fu, Z., Lu, Y., Wu, X., Han, X., Chen, M., Lu, C., Xia, Y., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0568-y · Cited by 91
Epigenetic Deregulation of Apoptosis in Cancers
Ozyerli‐Goknar, E., & Onder, T. B. (2021) · Cancers · doi:10.3390/cancers13133210 · Cited by 101
The promises and pitfalls of epigenetic therapies in solid tumours
Graham, J. S., Kaye, S. B., & Brown, R. E. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.003 · Cited by 92
Amyloid-like Behavior in Abiotic, Amphiphilic Foldamers
Bradford, V. J., & Iverson, B. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0780840 · Cited by 88
Borgohain, M. P., Haridhasapavalan, K. K., Dey, C., Adhikari, P., & Thummer, R. P. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9861-6 · Cited by 89
The Third-Generation Sequencing Challenge: Novel Insights for the Omic Sciences
Scarano, C., Veneruso, I., Simone, R. R. D., Bonito, G. D., Secondino, A., & D’Argenio, V. (2024) · Biomolecules · doi:10.3390/biom14050568 · Cited by 95
“These features may have a role in promoting cancer; indeed, the genome hypomethylation may cause chromosomal instability [64] and could also determine the aberrant activation of specific oncogenes when occurring in their promoter regions [65].”
BackgroundHoshimoto, S., Kuo, C. T., Chong, K. K., Takeshima, T., Takei, Y., Li, M. W., Huang, S. K., Sim, M., Morton, D. L., & Hoon, D. S. �. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.36 · Cited by 89
“The former has been linked to transcriptional silencing(Jones and Baylin, 2007), but the latter is poorly understood in cancer progression(de Maat et al., 2010a; de Maat et al., 2010b; Eden et al., 2003; Gaudet et al., 2003; Sunami et al., 2011).”
BackgroundMicroRNA regulatory networks in idiopathic pulmonary fibrosis
Pandit, K. V., & Milošević, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0101 · Cited by 87
Age-associated epigenetic modifications in human DNA increase its immunogenicity
Agrawal, A., Tay, J., Yang, G., Agrawal, S., & Gupta, S. (2010) · Aging · doi:10.18632/aging.100121 · Cited by 103
“This is believed to be poor prognosis for malignancies [14, 15].”
BackgroundVerma, M., Maruvada, P., & Srivastava, S. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490516922 · Cited by 93
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
Goldman, S. L., Hassan, C., Khunte, M., Soldatenko, A., Jong, Y., Afshinnekoo, E., & Mason, C. E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00133 · Cited by 101
Epigenetic regulation of cancer stem cell formation and maintenance
French, R., & Pauklin, S. (2020) · International Journal of Cancer · doi:10.1002/ijc.33398 · Cited by 92
“However, global hypomethylation in intergenic regions causes oncogene activation and ultimately results in genomic instability.(15,16)”
BackgroundRegulation of Expression and Activity of DNA (Cytosine-5) Methyltransferases in Mammalian Cells
Kinney, S. R. M., & Pradhan, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387685-0.00009-3 · Cited by 93
Tryndyak, V. (2005) · Carcinogenesis · doi:10.1093/carcin/bgl050 · Cited by 84
Cordier, S., Monfort, C., Filippini, G., Preston‐Martin, S., Lubin, F., Mueller, B. A., Holly, E. A., Peris‐Bonet, R., McCredie, M. R. E., Choi, W. N., et al. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh154 · Cited by 87
“Alternatively, epigenetic modifications may occur in germinal or somatic cells that may result in increased cancer risk for the conceptus (6, 7).”
BackgroundEpigenetic and Disease Targets by Polyphenols
Pan, M., Lai, C., Wu, J.-C., & Ho, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319340010 · Cited by 90
Epigenetics and epigenetic alterations in pancreatic cancer.
Omura, N., & Goggins, M. (2009) · PubMed · Cited by 100
Casalino, L., & Verde, P. (2020) · Genes · doi:10.3390/genes11080922 · Cited by 91
“A seminal evidence has been provided by mouse models in which a strong hypomorphic allele or deletion of Dnmt1 causes DNA hypomethylation and genomic instability leading to aggressive T-cell-induced tumorigenesis, associated with increased mutation rates and aneuploidies [35].”
Background
Metadata
- Authors
- Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- University of California, San Francisco (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Science
- Published
- 2003-04-18
- Volume
- 300
- Issue
- 5618
- Pages
- 489-492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1990381590
- Cited by
- 1,499
- References
- 34
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 20 · 2023: 36 · 2022: 40 · 2021: 43 · 2020: 52 · 2019: 50 · 2018: 48 · 2017: 48 · 2016: 63 · 2015: 75 · 2014: 57 · 2013: 94 · 2012: 99
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Cancer Institute (R01CA087869, CA 87869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA hypomethylation, DNMT1, T-cell lymphoma, tumor induction, epigenetic silencing, chromosomal instability, mouse model
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alleles, Animals, Birth Weight, Cell Transformation, Neoplastic, Chromosome Aberrations, DNA (Cytosine-5-)-Methyltransferases, Heterozygote, Mice, Transgenic, Moloney murine leukemia virus, Trisomy, Virus Activation, Gene Rearrangement, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Gene Expression, Gene Expression Regulation, Neoplastic, Genes, myc, Lymphoma, T-Cell, DNA Methylation, Loss of Heterozygosity, Endogenous Retroviruses, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.